TROW
56
6
LLY
68
4
IRM
31
3
NI
58
2
SLG
60
4
WHR
57
-5
MTCH
53
2
SJM
46
7
DHI
52
2
STT
50
5
BBY
44
-2
K
45
3
ALL
43
3
D
48
3
VMC
60
-2
TRIP
66
3
SHW
58
2
HPE
63
2
WEC
53
5
EQR
37
3
TROW
56
6
LLY
68
4
IRM
31
3
NI
58
2
SLG
60
4
WHR
57
-5
MTCH
53
2
SJM
46
7
DHI
52
2
STT
50
5
BBY
44
-2
K
45
3
ALL
43
3
D
48
3
VMC
60
-2
TRIP
66
3
SHW
58
2
HPE
63
2
WEC
53
5
EQR
37
3
Financhill
Back

Replimune Group 10K Form

Buy
64

REPL
Replimune Group

Last Price:
$12.53
Seasonality Move:
-4.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive REPL News And Ratings

See the #1 stock for the next 7 days that we like better than REPL

REPL Financial Statistics

Sales & Book Value

Annual Sales: $5K
Cash Flow: $-54.9M
Price / Cash Flow: 0
Annual Sales: $5.39
Price / Book: 2.34

Profitability

EPS (TTM): -3.07000
Net Income (TTM): $-247.3M
Gross Margin: $5K
Return on Equity: 0%
Return on Assets: 0%

Replimune Group Earnings Forecast

Key Replimune Group Financial Ratios

  • The Gross Profit Margin over the past 1 years for REPL is 100.00%.
  • The Selling, General & Administrative Expenses for REPL have been equal to 1,021,272.73% of Gross Profit Margin.
  • Per Share Earnings over the last 9 years have been positive in 1 years.

Replimune Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: REPL
CUSIP: 76029N
Website: replimune.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

REPL Technical Analysis vs Fundamental Analysis

Buy
64
Replimune Group (REPL) is a Buy

Is Replimune Group a Buy or a Sell?

  • Replimune Group stock is rated a Buy
    The current Replimune Group [REPL] share price is $12.63. The Score for REPL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.